The takeover of Alere is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold shares of Alere Inc (NYSE:ALR), concerning whether the takeover of Alere Inc by Abbott is unfair.
Investors who purchased shares of Alere Inc (NYSE:ALR) and currently hold any of those NYSE:ALR shares have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 – 1554.
The investigation by a law firm concerns whether certain officers and directors of Alere Inc breached their fiduciary duties owed to (NYSE:ALR investors in connection with the proposed acquisition.
On February 1, 2016, Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced an agreement for Abbott to acquire Alere. Under the terms of the agreement, Abbott will pay $56 per common share at a total expected equity value of $5.8 billion.
However, given that at least one analyst has set the high target price for NYSE:ALR shares at $60.00 per share, the investigation concerns whether the offer is unfair to NYSE:ALR stockholders. More specifically, the investigation concerns whether the Alere Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders’ best interests in connection with the proposed sale.
Shares of Alere Inc (NYSE:ALR) closed at $53.20 per share on February 4, 2016.
Those who are current investors in Alere Inc shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.